Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Chemoresistant
100%
Nanotherapeutics
100%
Epithelial Ovarian Cancer
100%
Reactive Oxygen Species
42%
Cisplatin
42%
Multidrug-resistant
28%
A2780
28%
Intracellular Reactive Oxygen Species
28%
Platinum-based
28%
Nanoparticles
14%
Tumor Growth in Vivo
14%
Cytotoxicity
14%
Therapeutic Efficacy
14%
Poor Prognosis
14%
Nephrotoxicity
14%
Cancer Tumor
14%
Inducer
14%
Doxorubicin
14%
Cardiac Toxicity
14%
Non-cancer
14%
Drug Resistance
14%
Minimal Impact
14%
Ovarian Cancer Patients
14%
Docetaxel
14%
Hepatotoxicity
14%
Hematotoxicity
14%
Gynecologic Malignancies
14%
Reactive Oxygen Species Level
14%
Tumor Model
14%
Toxicity Profile
14%
Toxicity Profiling
14%
Taxanes
14%
Anthracyclines
14%
Ovarian Epithelial Cancer
14%
Human Ovarian Cancer Cell
14%
Subcutaneous Tumor
14%
A2780 Cells
14%
Chemoresistance
14%
Platinum Drugs
14%
Cisplatin Resistance
14%
Cancer Cell Death
14%
Taxane-based Chemotherapy
14%
Polyamic Acid
14%
Intraperitoneal Tumor
14%
Aminopolymer
14%
Pharmacology, Toxicology and Pharmaceutical Science
Ovary Carcinoma
100%
Reactive Oxygen Metabolite
62%
Cisplatin
50%
Drug Resistance
25%
Taxane
25%
Malignant Neoplasm
12%
Nanoparticle
12%
Combination Therapy
12%
Tumor Growth
12%
Cytotoxicity
12%
Chemotherapy
12%
Nephrotoxicity
12%
Doxorubicin
12%
Cardiotoxicity
12%
Hepatotoxicity
12%
Docetaxel
12%
Tumor Model
12%
Anthracycline
12%
Blood Toxicity
12%
Polyaminoacid
12%